Accuray | ARAY - 销售和管理费用

金融业

USD

USD 448.01M

现金及等价物

USD 41.3M

USD 116.17M

USD 292.39M

USD 199.44M

USD 170.24M

股息收益率

0

USD 11.38M

USD -685K

1.02K

EPS每股收益

USD 0.02

股本和储备

USD 53.42M

USD 41.89M

债务利息支出

USD 2.88M

USD 124.78M

USD 37.7M

USD 2.54M

USD 37.19M

USD 4.71M

普通股股本

USD 100K

91.13

USD 3.23M

USD 116.17M

销售和管理费用

USD 124.78M

USD 150.96M

贸易债权人

USD 43.52M

应收帐款人

USD 91.79M

	销售和管理费用	更改		日
Abbott	USD 3.27B		138M	2026-03
Accuray	USD 124.78M		2.54M	2025-12
AngioDynamics	USD 36.57M		3.79M	2025-09
Artivion	USD 55.75M		4.54M	2025-12
AtriCure	USD 84.55M		6.21M	2026-03
Boston Scientific	USD 1.78B		53M	2026-03
Edwards Lifesciences	USD 522.2M		80.7M	2026-03
Inogen	USD 43.77M		510K	2024-06
Mesa Laboratories	USD 27.31M		380K	2024-09
Orthofix International	USD 130.35M		11.31M	2025-12
Surmodics	USD 11.4M		3.18M	2025-06
Tandem Diabetes Care	USD 99.86M		5.34M	2025-12
Trinity Biotech	USD 6.19M		2.18M	2025-09